Okay, let's tackle this question. The patient is a 60-year-old man with symptoms like fatigue, weight loss, and left hypochondrium heaviness. The lab results show a high total leukocyte count (5 lakhs/mm³), and the differential count has a lot of myelocytes and metamyelocytes. Hmm, so this looks like a myeloproliferative disorder.

The key here is the peripheral blood findings. The presence of immature myeloid cells (like myelocytes and metamyelocytes) suggests a chronic myeloid leukemia (CML) because of the left shift in the neutrophil series. CML is known for the Philadelphia chromosome, which is a translocation between chromosomes 9 and 22, leading to the BCR-ABL fusion gene. That's the classic cytogenetic abnormality here.

Now, looking at the options (though they're not listed), the correct answer should be the Philadelphia chromosome. The other options might include things like trisomy 8, which is seen in myelodysplastic syndromes, or maybe something like t(15;17) for AML with PML-RARα, which is acute. Since the patient has a chronic presentation with these blast counts not too high (only 3%), it's more likely CML. The basophilia and left shift are also classic for CML. The other myeloproliferative disorders like polycythemia vera or essential thrombocythemia don't typically have such a prominent myeloid left shift with blasts and myelocytes. So the most likely cytogenetic abnormality is the Philadelphia chromosome.

**Core Concept**
This question tests the recognition of chronic myeloid leukemia (CML) and its associated cytogenetic abnormality. The hallmark of CML is the *Philadelphia chromosome*, a reciprocal translocation between chromosomes 9 and 22 (*t(9;22)(q34;q11)*), which creates the *BCR-ABL1* fusion gene. This leads to constitutive tyrosine kinase activity driving uncontrolled myeloid proliferation.

**Why the Correct Answer is Right**
The clinical presentation (fatigue, weight loss, splenomegaly) and lab findings (leukocytosis with myelocytes/metamyelocytes, basophilia) are classic for CML in the *chronic phase*. The Philadelphia chromosome is the defining abnormality in 95% of CML cases. The *BCR-ABL1* fusion protein causes aberrant signaling through pathways like JAK-STAT and RAS-MAPK, resulting in clonal myeloid expansion. Splenomegaly occurs due to extramedullary hematopoiesis.

**Why Each Wrong Option is Incorrect**
**Option A:** *Trisomy 8* is associated with myelodysplastic syndromes/myeloproliferative neoplasms but lacks immature myeloid cells in peripheral blood.
**Option B:** *t(15;17)* causes acute promyelocytic leukemia (APL), characterized by Auer rods and PML-RARA fusion, not chronic myeloid features.
**Option C:** *Inv(16)* is seen in acute myeloid leukemia (AML-M

✓ Correct Answer: B. t (9; 22)